We found that CQ can reverse the promotion of LOXL2 on glioma cell migration (Supplementary Figures 9A, B) and invasion (Figure 5F) and can inhibit the expression of EMT-related markers (Figure 5G) caused by LOXL2 overexpression. The gene discussed is LOXL2; the disease is central nervous system cancer.